Pharmacy benefit managers, which companies hire to reduce their prescription drug costs, inflate prescription drug costs, Federal Trade Commission investigators found. The FTC research also said PBMs, which act as middlemen in the industry, inflate costs and pressure independently owned pharmacies. PBMs said the study was flawed. 'The FTC's interim report lays out how dominant […]
The post FTC blames pharmacy benefit managers for high drug prices appeared first on The Black Chronicle.
